Severe influenza infection represents a leading cause of global morbidity and mortality. Although influenza is primarily considered a viral infection that results in pathology limited to the respiratory system, clinical reports suggest that influenza infection is frequently associated with a number of clinical syndromes that involve organ systems outside the respiratory tract. A comprehensive MEDLINE literature review of articles pertaining to extra-pulmonary complications of influenza infection, using organspecific search terms, yielded 218 articles including case reports, epidemiologic investigations, and autopsy studies that were reviewed to determine the clinical involvement of other organs. The most frequently described clinical entities were viral myocarditis and viral encephalitis. Recognition of these extra-pulmonary complications is critical to determining the true burden of influenza infection and initiating organ-specific supportive care.
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K E Y W O R D S
extra-pulmonary complications, influenza, respiratory virus, viral encephalitis, viral myocarditis . Multiple influenza-associated extra-pulmonary complications can also occur simultaneously in a single patient. 4 Improved recognition of these complications will improve the understanding of the morbidity and mortality caused by influenza viruses worldwide and allow for better organ-specific supportive care to reduce influenza-associated morbidity and mortality. In an attempt to better understand the burden of extra-pulmonary complications of influenza infection, a comprehensive literature review was performed.
| INTRODUCTION
Severe
| Search strategy and selection criteria
The authors undertook a comprehensive literature review by querying MEDLINE (PubMed database) for articles in English pertaining to extra-pulmonary complications of influenza infection published between January 1, 1959, and July 1, 2016, using organ-specific search terms determined by author consensus (Table 1) .
Two authors independently reviewed the abstracts for inclusion.
Studies that were not in English, included only pediatric populations, focused on extra-pulmonary complications of influenza vaccines or antiviral therapy were not included ( Figure 1) . A separate comprehensive review of extra-pulmonary manifestations in pediatric populations is concurrently being prepared.
The search terms yielded 2752 articles and 2514 were excluded ( Figure 1 ). Two authors independently reviewed 241 articles. For case reports and case summaries, specific data regarding demographics, clinical features, and outcomes were extracted. References of the included articles were also reviewed to ensure complete capture of relevant articles.
| FINDINGS

| Cardiovascular complications of influenza
Cardiovascular disease and influenza have long been associated due to an overlap in the peak incidence of each disease during winter months. Epidemiologic studies have also noted an increase in cardiovascular deaths during influenza epidemics indicating that cardiovascular complications of influenza infection, including exacerbation of heart failure, acute ischemic heart disease, and less often acute myocarditis, are important contributors to morbidity and mortality during influenza infection. [5] [6] [7] Additionally, studies from vaccine and antiviral therapeutic trials also highlight an important association and suggest that specific pharmacologic strategies may prevent or reduce the risk of many of the cardiovascular complications of influenza.
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| Myocarditis
Clinically diagnosed myocarditis, based on a combination of symptoms, elevated cardiac enzymes, and echocardiographic findings, has been reported in approximately 0.4%-13% of hospitalized adult patients with documented influenza. 11, 12 Myocarditis may, however, be a more common feature in fatal influenza infections as classic histopathologic findings, including cellular infiltration and myocyte necrosis, have been found in 30%-50% of patients at autopsy despite cardiac involvement not being clinically suspected. [13] [14] [15] Additionally, influenza-related myocarditis often occurs in the absence of more severe respiratory complications as only 40% (6/15) of patients with myocarditis in one study also had documented pneumonia. 16 There have been approximately 44 cases of influenza-associated myocarditis in adult patients described in case reports and case series (Table 2) . 15, Among those reported, 52% (23/44) The clinical course of influenza-associated myocarditis is variable, with the majority of patients experiencing an acute onset of symptoms related to cardiac dysfunction, including chest pain, dyspnea, syncope, hypotension, and arrhythmia, between days 4 and 7 following the initial symptoms of viral infection. 43 Most patients, with admission symptoms reported, presented to the hospital with cardiac symptoms (97%; 34/36), suggesting that it was the cardiovascular manifestations that were responsible for the patient seeking medical attention rather than typical respiratory symptoms. Of the 37 cases that documented time to onset of cardiac symptoms, only 3 (8%) developed symptoms late in their course as defined by greater than 10 days after initial viral symptoms. 15, 20, 36 The severity of influenza-associated myocarditis spans a wide spectrum ranging from asymptomatic to severe disease. Although recognition of influenza-associated cardiovascular complications occurs primarily in patients with cardiac symptoms, there is some suggestion that a significant proportion of patients with influenza infection may suffer clinically unrecognized, asymptomatic myocardial injury. A Japanese study of 96 patients found that 11% of patients who were infected with influenza A (H3N2) had elevated myosin light-chain I concentrations, a marker for myocardial injury. 44 However, the degree of injury is likely mild as another study of 152 slightly younger patients in the UK found no elevation of cardiac troponin I and T levels, which are more sensitive markers of cardiac injury. 45 A third study followed 30 previously healthy young adults diagnosed with influenza infection for 28 days after enrollment with serial electrocardiograms, echocardiograms, and cardiac enzymes and found that no enrolled patients had clinically significant changes in their cardiac studies or cardiac enzymes. 46 At the other end of the spectrum, a number of cardiac-specific complications have been described in the setting of influenzaassociated myocarditis including heart failure, arrhythmias, pericardial effusion, and cardiac tamponade. Congestive heart failure, as diagnosed by regional or global hypokinesis on echo/MRI, is the most common complication and is seen in 84% (37/44) of patients with influenza-associated myocarditis. More than half (23/37; 62%) of patients with heart failure from influenza-associated myocarditis required advanced cardiac support therapies. Thirty-eight percent (14/37) were treated with intra-aortic balloon pumps (IABP), 27%
(10/37) with percutaneous cardiopulmonary support, and 16% (6/37) who required extracorporeal membrane oxygenation. Two patients had a biventricular assist device (BiVAD) implanted, one had a left ventricular assist device placed, one had a surgical atrial septostomy performed, and one patient underwent a heart transplant which failed requiring placement of an artificial heart (Jarvik).
Although heart failure associated with influenza can be severe and cause significant hemodynamic compromise requiring advanced cardiac support therapies, recovery of cardiac function has been documented frequently in survivors. Of the 37 patients who were diagnosed with heart failure in the setting of influenza-associated myocarditis, with ejection fractions ranging from 8% to 50%, 26 (70%)
ultimately experienced resolution of their systolic dysfunction on echocardiogram. All of the patients (n = 13) who had time to resolution reported did so within 20 days of the onset of dysfunction.
Pericardial effusions of variable size and significance also frequently complicate influenza-associated myocarditis. Thirteen of 44 (30%) patients with influenza-associated myocarditis had pericardial effusions on echocardiogram, and 4 had evidence of tamponade requiring pericardiocentesis. Other reported complications include eight cases of life-threatening ventricular arrhythmias and one case of myocardial infarction (MI). Additionally, recurrent myocarditis in the setting of influenza infection has been reported in 2 cases. One patient had two prior episodes of myocarditis and then a third elicited in the setting of influenza infection, consistent with influenza infection exacerbating an underlying condition. 29 Another patient had resolution of his influenza-associated myocarditis followed by recurrent myocarditis 22 days after initial presentation.
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The underlying pathophysiology of influenza-associated myocarditis remains unclear. In a study of endomyocardial biopsies from 38 patients with viral and non-viral mediated myocarditis, the viral etiology was determined by PCR in 20 patients including 2 with influenza. 47 In another study of 29 patients with fatal influenza B infection with cardiac tissue samples available at autopsy, only one patient had influenza B detected by RT-PCR. 13 Of the case reports described above, the pericardial fluid of one patient was found to be positive for influenza A(H1N1)pdm09by PCR,. 24 Another patient had evidence of influenza A(H1N1) in her myocardium identified by both immunofluorescence and viral culture after her heart was replaced by a Jarvik artificial heart on hospital day 4; in this case, influenza A was also detected in her blood. 32 Evidence of virus in these cases suggests a potential role for direct viral invasion as the underlying pathogenic mechanism, although PCR positivity alone does not provide definitive evidence. Alternatively, the increased incidence of myocarditis among patients with more severe influenza infection may implicate an exaggerated immune response in the pathogenesis, as increased serum cytokines are commonly found in severe influenza. [48] [49] [50] [51] [52] Increasing levels of IL-8, IL-10, IL-6, and TNF-α were reported in one patient with influenza-associated myocarditis concurrent with her clinical deterioration supporting the role of systemic inflammation as a driver of influenza-associated myopericarditis. 53 Similarly, elevated levels of T A B L E 2 (Continued) care, and the mortality among the reported 43 patients with influenzaassociated myocarditis is approximately 23%.
Heart failure independent of myocarditis has also been described in the course of influenza infection. In one series of 124 patients hospitalized with influenza infection, 24 had echocardiograms (echo) performed and 6 (25%) of those patients had new or worsened left ventricular dysfunction. 54 Four of these patients experienced at least partial improvement in ejection fraction by echo at 4-22 days. A second retrospective, multicenter study looked at 23 ICU patients with A(H1N1)pdm09 infection and found that right ventricular dysfunction (48%) was more common than left ventricular dysfunction (17%) and was higher in prevalence than generally reported in patients with acute respiratory distress syndrome (ARDS) (10-25%). 
| Ischemic heart disease
Several large epidemiologic studies in Russia, the United States, the United Kingdom, and Hong Kong have revealed a temporal association between the circulation of influenza viruses and an increase in hospitalizations and deaths due to ischemic heart disease (IHD). 5, [56] [57] [58] Additionally, a significant increase in the number of IHD deaths has also been detected during epidemic periods. 57 Two large studies utilizing self-controlled case series analysis found that rates of a first MI were highest in the first 3 days following an acute respiratory infection with a reduction in the effect over time. 6, 58 Another study of 600 patients in the Veterans Administration system found that 143 (24%) patients who tested positive for influenza had acute cardiac injury, 80% of which occurred within 3 days of the influenza diagnosis and 70 (49%) were MIs. The remaining half had elevations in cardiac biomarkers due to acute congestive heart failure (8/143; 6%), myocarditis (6/143; 4%), atrial fibrillation (4/143; 3%), non-cardiac explanations (11/143; 8%), or no documented explanation (44/143; 31%). 59 In contrast, only 13 (3.6%) of 2287 patients diagnosed with an unspecified community-acquired pneumonia (CAP) were diagnosed with MI in the 30 days after CAP diagnosis. 60 Given the association between peak influenza activity and cardiovascular events, studies have evaluated the effect of influenza vaccination on the reduction of multiple cardiovascular end points ( Table 3 ).
The incidence of acute MI was significantly reduced in the 60 days following influenza vaccination in one self-controlled case series of the inactivated influenza vaccine. 61 This effect was most pronounced in the first 2 weeks after vaccination with a reduction of acute MI by 
63
A number of studies evaluating the impact of influenza vaccination on subsequent cardiovascular events have yielded mixed results.
In the FLUVACS study, the 100 subjects with a new MI who were randomized to receive an inactivated influenza vaccine experienced a significant decrease in the composite end point of cardiovascular death, non-fatal MI, or severe ischemia at 6 months (RR 0.50; 95%
CI 0.29-0.85) compared with those who received placebo. 8 Similarly, a case-control study of 218 patients with CAD in the United States demonstrated that the influenza vaccine was protective against a new MI in subjects who had already experienced an MI (OR 0.33; 95% CI 0.13-0.82). 9 However, a separate retrospective study of 1378 patients who had survived a prior MI found no association between influenza vaccination and reduction in a subsequent MI. 64 Taken together, these studies strongly suggest that influenza vaccination is associated with a reduction in initial MIs, while larger studies on secondary prevention are needed.
Only one retrospective study has evaluated the effect of neuraminidase inhibitors on the recurrence rate of cardiovascular disease following influenza infection. 10 Patients with a prior history of cardiovascular disease and acute influenza infection were prescribed oseltamivir and those who filled with prescription within 2 days suffered fewer recurrent MIs (0.2% vs 1.4%; P < .005) and less combined cardiac events, including MI, angina, stroke, heart failure, and sudden Influenza-associated IHD is posited to be driven by inflammation which is known to have a critical role in the development of acute coronary syndrome. 65 In apolipoprotein E-deficient mice, an animal model of atherosclerosis, animals that were infected with influenza A virus developed subendothelial and smooth muscle inflammatory infiltration with overlying platelets and fibrin strands in atherosclerotic plaques. 66 Additionally, the systemic pro-inflammatory response triggered by influenza infection is accompanied by significant procoagulant effects which may also play a role. 67 Viremia in influenza infection has been reported variably-one study of 139 patients with influenza A(H1N1)pdm09 infection reported viral RNA detected by RT-PCR in 14 patients (10%), which was associated with severe clinical disease and presence of the D222G/N mutation in the viral hemagglutinin protein. 68 Earlier studies in nonpandemic influenza strains identified viremia in up to 17% of patients. 69 At present, no human studies support the theory of direct virus invasion of the vascular bed. However, influenza A virus has been detected in the atherosclerotic arteries of apolipoprotein E-deficient mice that were infected, suggesting that this is a possibility. 70 There is also limited evidence, however, that prior infection may play a role in the development of chronic atherosclerosis. One cross-sectional study of patients referred for cardiac catheterization found that while influenza IgG seropositivity is not independently associated with IHD alone, patients who were seropositive for multiple pathogens were more likely to have IHD suggesting that cumulative infection burden may be related to development of atherosclerosis. 
| Stroke
Similar to ischemic cardiac complications, the risk of ischemic cerebral vascular accidents (CVA), or strokes, appears to be significantly increased in the days after a respiratory tract infection. 58 However, only two cases of ischemic CVA in the setting of influenza infection have been reported. One case of multiple strokes occurred in a young woman with disseminated intravascular coagulation who was critically ill. 72 The other case occurred in a 50-year-old woman with ARDS secondary to influenza A(H1N1) who developed multiple strokes in the territory of the right middle cerebral artery. 73 There may be indirect evidence of an association between influenza and CVAs, but data from influenza vaccination and neuraminidase inhibitors are conflicting. 74, 75 One case-control study in France found that the risk of stroke was reduced in subjects vaccinated in that year compared to those not vaccinated (OR 0.50, 95% CI 0.26-0.94). Protection was strongest in patients under the age of 75. 76 Similarly, another study in Germany also found a reduced risk for stroke with influenza vaccination (OR 0.46, 95% CI 0.28-0.77). 77 When stratified by type of stroke, the reduced risk was most significant for ischemic stroke with a trend toward protection in hemorrhagic stroke and no protection against transient ischemic attacks (TIA). In contrast, a large study of over 23 000 patients from two prospective cohorts (OPTIC and ARMISTAD) and a randomized trial (PERFORM) did not find any association between influenza vaccination and cerebrovascular accidents, although patients in this study had higher levels of known CVA risk factors including dyslipidemia and hypertension. 78 In this study, propensity score matching was used to compensate for potential healthy user bias that may explain the significant benefit seen in previous studies. Lastly, there is evidence that treatment with the neuraminidase inhibitor oseltamivir in the setting of acute influenza infection reduces the risk of stroke. 79 The protective effect remained significant in patients under the age of 65 for 6 months after infection, whereas in patients 65 and older, the association was significant only in the first month after infection. 79 Cardiac complications associated with influenza infection, including myocarditis, ischemic heart disease, and stroke, can have a significant impact on influenza mortality and morbidity. Early recognition of these complications is critical to initiate organ-specific supportive care
Additionally, the protective role of influenza vaccines against an initial MI and early initiation of neuraminidase inhibitor with a decrease in combined cardiovascular end points highlights important preventative and therapeutic opportunities to reduce influenza-associated cardiovascular complications.
| Neurologic complications of influenza
Influenza infection can lead to a variety of neurologic complications including a number of specific clinical entities grouped together as influenza-associated encephalitis or encephalopathy (IAE), as well as a separate syndrome known as post-influenza encephalitis, GBS, Reye's syndrome, and Parkinsonian symptoms. While neurologic complications are more frequently noted in pediatric populations, they are also increasingly being recognized in adults. 80 The neurologic manifestations of influenza have been primarily reported in Japan, which may be due to greater recognition in that region. However, a study of influenza-associated neurologic complications in the USA did find that a disproportionate number of Asian/Pacific Islanders were affected (12.79/1 000 000) compared with white, non-Hispanic patients (3.09/1 000 000) suggesting a possible underlying genetic predisposition. AESD is characterized by a biphasic course, febrile seizures, and subcortical white matter lesions on MRI, whereas MERS, which is characterized typically by a lesion of the splenium of the corpus callosum, is associated with a milder course and often a good clinical outcome. 82 The spectrum of influenza-associated encephalitis can also be expanded to include posterior reversible encephalopathy syndrome (PRES), which is associated with areas of edema on MRI and can occur days to weeks after initial viral symptoms, and acute hemorrhagic leukoencephalopathy (AHLE), characterized by a rapid and fulminant demyelination and inflammation of the white matter. However, these entities are primarily described in the pediatric literature as IAE is more frequently recognized and reported in children less than 5 years of age. The incidence of IAE in adults has been reported in up to 4% of hospitalized adults, although case reports rarely apply the terminology of specific clinical syndromes beyond IAE. 83 There have been 28 reported cases of IAE in adults with 7 further differentiating the clinical syndromes including 3 cases of PRES, 2 cases of MERS, and 2 cases of AHLE (Table 4) . 4, In these reports, however, there was no discussion of whether the location of the viral RNA correlated to imaging findings. 89, 90 All patients were treated with supportive care, and 21 of the 28 patients reported were treated with neuraminidase inhibitors including oseltamivir, peramivir, and/or zanamivir. Three patients (11%) were additionally treated with corticosteroids, and one patient underwent plasma exchange. 85, 87, 98 Overall, 79% (22/28) of adult patients with IAE survived. However, 25% (7/28) of patients suffered residual neurologic defects, primarily including motor weakness and cognitive defects at follow-up within 3 months of the initial illness. Long-term follow-up beyond 3 months has not been reported.
A separate entity, post-influenza encephalopathy has also been described, in which the development of neurologic symptoms occurs after the resolution of the respiratory symptoms but within 3 weeks of the influenza diagnosis. 83 One case report described post-influenza severe influenza illness rather than as a direct effect of the virus itself. 83 A dysregulated immune response has also been posited to drive neurologic complications in influenza. Serum levels of cytokines IL-6, TNF-alpha, and IL-10 were found to be significantly elevated in pediatric patients with IAE as compared to influenza-infected patients without neurologic involvement. 110, 111 Similarly, CSF levels of IL-6
were also found to be significantly elevated in pediatric patients with IAE compared to children with neurologic disorders and not infected with influenza. 112 Transcriptomic profiling has also demonstrated elevated levels of IL-6, IL-10, and TNF-alpha mRNA in patients with IAE compared to those with influenza-associated febrile seizures in the setting of equivalent viral loads. 111 One study demonstrated significantly greater serum levels of soluble CD163, a scavenger receptor for hemoglobin-haptoglobin complexes expressed by monocytes and macrophages in patients with more severe forms of IAE such as ANE compared to those with milder disease suggesting a dose-response association. 113 Although IAE has been described in case reports from around the world, there appears to be a higher incidence in East Asian populations, suggesting the possibility of a genetic predisposition. In a study of 29 Japanese patients with AESD or ANE, a higher frequency of several single nucleotide polymorphisms in the carnitine palmitoyl transferase II gene was found compared with healthy controls. 114 Another study identified an association between AESD and a genetic variant of the adenosine A2A receptor (ADORA2A) which may alter cyclic AMP signaling. 115 with an influenza-like illness. 128 In a study of 405 French patients with GBS, peaks in the incidence of cases without an identified etiologic agent are also temporally associated 1-2 months following peaks in the incidence of influenza-like illnesses. 120 In an additional analysis of 73 patients with GBS without a clear etiology in the same study, 10 (13.7%) had serologic evidence of recent influenza A infection and 4 (5.5%) with recent influenza B infection.
| Guillain-Barre syndrome
Although the 1976 influenza swine flu vaccination program was stopped prematurely due to the increased development of GBS in subjects who received this particular vaccine, recent studies of seasonal influenza demonstrate a safe reduction in GBS in vaccinated individuals. Evidence from a study in the UK demonstrated no increased risk of GBS associated with the seasonal influenza vaccine. 129 Similarly, a Canadian study using universal healthcare system databases to examine the risk of GBS after exposure to the seasonal trivalent inactivated influenza vaccine found a lower attributable risk of admission for GBS (1.03 per million healthcare encounters for influenza) for those vaccinated compared with unvaccinated individuals (17.2 per million healthcare encounters for influenza). 130 Taken together, these studies demonstrate that while there may be an increase in GBS associated with influenza infection, vaccination appears to be protective.
While the mechanism underlying influenza-associated GBS is not known, evidence from C. jejuni-induced GBS suggests that molecular mimicry may play a role as the C. jejuni lipopolysaccharide induces an antiganglioside antibody response resulting in the immune-mediated polyneuropathy of GBS. However, of the five cases of influenzaassociated GBS reported, only one patient had detectable antiganglioside antibodies. 121 Additionally, in a study of 23 patients infected with influenza A(H1N1)pdm09, only one patient tested weakly positive for one antiganglioside antibody, anti-GM1, and none of the influenzainfected patients were diagnosed with GBS. One patient with influenza-associated transverse myelitis was found to have high titers of myelin oligodendrocyte glycoprotein antibodies, suggesting a pathogenic role. 137 Additionally, one patient had recurrent ADEM after a second influenza infection 6 months after his first episode and another had recurrent ADEM after an influenza vaccination suggesting a role for genetic predisposition or formation of an immunologic mechanism.
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| Other neurologic complications of influenza infection
Narcolepsy is a sleep disorder characterized by excessive daytime sleepiness with nighttime disturbance and can be associated with cataplexy, the sudden loss of muscle tone triggered by strong emotions. It is caused by loss of neurons in the hypothalamus that secrete hypocretin, neuropeptides involved in regulation of arousal and wakefulness.
However, upper respiratory infections have also been loosely linked to disease presentation given a temporal association between infection and narcolepsy symptom onset, including Streptococcus pyogenes infection. 138 A retrospective analysis of the onset of narcolepsy in 629 patients in China demonstrated a threefold increase in the incidence of narcolepsy after the 2009 H1N1 influenza pandemic. 139 In this study, The neurologic complications of influenza infection are extremely variable in presentation and strength of association. In particular, IAE is poorly described in adults and requires MRI for diagnosis in 50% of cases despite being associated with death in 21% of reported cases.
Low threshold for diagnostic evaluation and early initiation of antiviral treatment and supportive care remains critical.
| Musculoskeletal complications of influenza
While myalgias are a common complaint among individuals with many viral infections, the development of rhabdomyolysis represents a less common but more serious complication. In cases of virusassociated rhabdomyolysis, influenza is identified as the most common etiology. 151, 152 There have been approximately 27 reported cases of rhabdomyolysis in the setting of influenza infection, although this likely represents a small fraction of the total cases as myositis and/or rhabdomyolysis have infrequently been reported prior to the 2009 A(H1N1) pandemic (Table 5) . 4, 22, [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] Among 18 patients in Mexico with influenza A(H1N1)pdm09 infection, 62% of patients had mild-to-moderate elevations of creatinine kinase (CK). 166 Of the 27 patients reported with influenza-associated rhabdomyolysis, 15 (55%) were women and 12 (44%) were over the age of 60. The majority of these patients were in- 
| Ocular manifestations of influenza infection
Influenza-associated ocular disease can result from direct conjunctival invasion by influenza virus and presents most commonly as a conjunctivitis although retinopathy, uveal effusion syndrome, and optic neuritis have also been reported. 173 Avian influenza viruses of the H7 subtype in particular, with the exception of zoonotic A(H7N9) display a prominent ocular tropism compared to other strains of influenza.
The human conjunctiva expresses the alpha 2-3 sialic acid residue which is preferentially recognized by avian influenza viruses but lacks the alpha-2,6 sialic acid residue that is classically recognized by human influenza viruses. 174 During an outbreak of avian A(H7N7) influenza in the Netherlands, 91% (75/82) of patients presented with conjunctivitis alone and 6% (5/82) had both conjunctivitis and influenza-like illness. 175, 176 In British Columbia and Mexico, during outbreaks of highly pathogenic avian A(H7N3) infection in poultry, two patients in each country were diagnosed with infection after presenting with conjunctivitis. 177, 178 In a study of 194 individuals who were actively in- Conjunctivitis has also been reported in association with the A(H1N1)pdm09 virus. 174 In a study of 89 patients with H1N1 infection, 58 (65%) presented with conjunctivitis, 7 patients (8%) presented with uveal effusion syndrome-a unilateral red painful eye associated with severe visual loss-and another 3 (3%) presented with optic neuritis. 173 Both the uveal effusion syndrome and the optic neuritis responded to treatment with corticosteroids. More severe ocular manifestations have been reported in association with influenza A(H1N1) pdm09 infection-two cases of acute retinitis and a case of bleeding follicular conjunctivitis. [181] [182] [183] All three patients recovered their vision although one did have persistently impaired color perception. In the patient with bleeding follicular conjunctivitis, viral RNA was detected by RT-PCR in the affected eye and in one of the retinitis cases, the patient had vitreous antibodies to A(H1N1).
The ophthalmologic complications of influenza are reported variably and may be strain-specific based on the evidence reviewed.
However, understanding of these complications is likely limited by under-recognition and under-reporting.
| Renal complications of influenza
Influenza infection can also affect renal function through a number of complications including acute kidney injury (AKI), acute glomerulonephritis, minimal change disease, and acute tubulointerstitial nephritis (ATN).
| Acute kidney injury (AKI)
Observational studies suggest the incidence of influenza-associated AKI ranges from 18% to 66% in patients cared for in an ICU setting. [184] [185] [186] The degree of renal failure can be quite severe, as 8%-22%
of patients ultimately require RRT during their hospitalization. 187 The four of those patients also had myoglobin pigment in the tubules consistent with rhabdomyolysis, and a fifth had evidence of thrombotic angiopathy. 191 Direct viral injury to the kidneys is another postulated mechanism of disease, but there is limited evidence to support this.
Influenza A(H1N1)pdm09 virus has been detected in the cytoplasm of glomerular macrophages in the kidneys of 4 of 5 patients in one post-mortem study; however, this may suggest circulating virus or simply the presence of viral genetic material in macrophages rather than direct invasion. 190 There is only one report of a patient with evidence of viral shedding in urine. 192 Renal complications in the setting of influenza infection, whether an exacerbation of an underlying condition or a novel consequence of the infection, remain poorly defined and warrant further investigation.
| Hepatic complications of influenza
Hepatic complications of influenza are rarely reported, yet recent reports suggest that liver injury occurs in the setting of influenza infection. [193] [194] [195] In an uncontrolled human challenge model of influenza infection, 4 of 15 human subjects experimentally inoculated with influenza developed elevated blood transaminase levels (greater than threefold the upper limit in two subjects). 196 Liver injury may be strainspecific as a greater proportion of 97 patients with A(H1N1)pdm09
infection had elevated AST and ALT (25.78% and 26.31%, respectively) compared with 86 patients infected with 2008 seasonal influenza virus-infected (18.6% and 7.36%, respectively). 193 Additionally, histopathologic evidence of centrizonal hemorrhagic necrosis was also reported in 78% of patients who died following A(H1N1)pdm09 virus infection. 197, 198 However, liver damage may be a marker of disease severity as liver function tests including transaminases, bilirubin, and GGT were also associated with duration of hospitalization, hypoxia, and CRP. 193 Similarly, transaminase elevations have been more commonly reported in severe cases of influenza including 60% (6/10) of patients infected with highly pathogenic avian A(H5N1) and in 66%
(73/111) of patients with A(H7N9) infection. 198, 199 Post immediately following infection and demonstrated a delayed response to corticosteroids. 203 Liver injury due to influenza infection, possibly secondary to systemic inflammation mediated by viral infection, appears to be present in a percentage of cases suggesting that liver enzymes should be monitored closely.
| Hematologic complications of influenza
Influenza infection is associated with a variety of hematologic complications including thromboembolic disease, thrombotic thrombocytopenic purpura (TTP), hemolytic-uremic syndrome (HUS), and hemophagocytic syndrome (HPS).
| Thromboembolic disease
Post-mortem studies of patients who died from influenza infection have offered conflicting evidence about the association between influenza infection and thromboembolic disease likely due to differences in study design. In eight cases of fatal influenza A(H1N1), a higher incidence of pulmonary thrombi (75%) was found in comparison with the reported frequency in intensive care unit patients at autopsy (5%). 204 
| Hemolytic-uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP)
Hemolytic-uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP), two overlapping thrombotic microangiopathic syndromes defined by non-immune-mediated hemolytic anemia, thrombocytopenia, AKI, and neurologic abnormalities, have been rarely associated with influenza infection in adults. Only four patients with influenzaassociated HUS or TTP have been described including one case that occurred in a renal transplant patient and one patient who had prior TTP and experienced a recurrence in the setting of influenza infection. [208] [209] [210] [211] It has been postulated that the viral neuraminidase protein unmasks the Thomsen-Friedenreich cryptoantigen, which has previously been implicated in atypical HUS. 208, 212 Alternatively, one patient with influenzaassociated TTP developed high titer antibodies against ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motic, member 13), a protein that cleaves von Willebrand factor (vWF) multimers. 209 The association between influenza and TTP, however, is based on a paucity of case reports and thus remains speculative.
| Hemophagocytic syndrome
Hemophagocytic syndrome (HPS) is a clinical condition characterized by activated macrophages and histiocytes leading to secretion of an extraordinary amount of cytokines and an uncontrolled phagocytosis of platelets, erythrocytes, and lymphocytes. It is an uncommon condition thought to be triggered by specific autoimmune conditions, infections, or malignancy. However, the pathologic finding may be more common than thought as one post-mortem review of six patients who died of influenza A(H5N1) infection all had evidence of hemophagocytosis in the bone marrow on autopsy. 213 Influenza has also been linked to the development of virus-associated hemophagocytic syndrome in three case reports. 36, 41, 214 Two of the patients had a prior history of an autoimmune condition that has been independently linked to HPS including one with systemic lupus erythematous and another with rheumatoid arthritis. 215 All patients were treated with high-dose steroids, and one was treated additionally with IVIG and all survived. The association between influenza infection and TTP and HPS provides further evidence that in addition to respiratory disease, influenza can exacerbate underlying conditions including activating or reactivating autoimmune conditions. Early recognition of the hematologic complications of influenza including TTP or HPS in influenza infection is critical to initiate specific therapeutic interventions.
| Endocrine complications of influenza
Patients with diabetes mellitus are considered high risk for severe influenza illness by the Center for Disease Control as infectious diseases are frequently the trigger for diabetic complications including diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar non-ketotic coma (HHNK). 216 The association with these diabetic complications and influenza was first reported in 1970, when 14 of 29 patients (48%) admitted to a hospital in Birmingham, England, also had respiratory complaints during a local outbreak of influenza. 217 Since then, there have been at least 4 case reports of DKA or HHNK in the setting of diagnosed influenza-3 with influenza A(H1N1) infection and one with influenza B. [218] [219] [220] Of those patients, 3 (75%) had no previous history of diabetes and the diagnosis was unmasked in the setting of influenza infection. The type of diabetes was not identified in most of the case reports except for one patient who had undetectable serum C-peptide levels after glucagon administration, suggesting a diagnosis of type I diabetes with no endogenous insulin secretion; however, this patient also did not have detectable anti-GAD or anti-IA-2 antibodies, the presence of which can be helpful in the diagnosis of late autoimmune diabetes in adults. 219 The relationship between diabetes and influenza infection is also supported by epidemiologic evidence from the Netherlands. Using data on national hospitalizations aggregated during time periods with increased diagnoses of influenza-like illness in 1976 and 1978, patients were significantly more likely to die of DKA than compared to periods when influenza-like illness rates were at baseline (25.7% vs 14.6%, P < .01). 221 This study also noted that the number of hospitalizations for DKA increased by 50% in 1978 compared to the two years prior and the year after. Although evidence is lacking to support a true association between influenza infection and endocrine complication as opposed to an exacerbation of an underlying disease, a high threshold of suspicious should be maintained in assessing for complications of HHNK or DKA.
| Limitations
The quality of the literature presented is limited as this review relies primarily on case reports, case series, and observational studies. The complications identified are also difficult to address in the context of severe systemic influenza infection as it is unclear if they are the consequence of the infection itself, systemic illness or shock in general, or an exacerbation of an otherwise underlying condition.
Additionally, publication bias likely exists as a disproportionately large amount of the literature comes from the 2009 H1N1 influenza pandemic. agency. The corresponding author has had full access to all data in the study and has had final responsibility for the decision to submit for publication.
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N/A. case-control studies, 3 basic science papers, 1 case series, and 1 case report. One of the case-control studies also addressed optic neuritis as a complication, and there were three additional case reports regarding acute retinitis and bleeding follicular conjunctivitis.
Ten articles were reviewed discussing the association of acute kidney injury in influenza infection, including 6 observational cohort studies, three autopsy studies, and one case report. Although the quality of the evidence is reasonably strong, the conclusions drawn are inconsistent.
Twelve manuscripts regarding hepatic complications in influenza infection were reviewed. This included 4 autopsy studies, 4 observational cohort studies, 3 case series, 1 human virus challenge study, and 1 case-control study. The quality of the evidence is overall weak to moderate and somewhat inconsistent as it remains unclear whether liver disease is directly related to influenza infection or whether it is simply a marker of severe infection.
Fourteen manuscripts were reviewed regarding hematologic complications of influenza infection. Four articles discussed the role of thromboembolic disease, including 2 case-control studies, 1 cohort study, and 1 autopsy study. There were five manuscripts reviewed concerning HUS/TTP in the setting of influenza, including 4 case reports and 1 review article. As the support was mostly dependent on case reports, the evidence is weak. Five articles addressed the link between hemophagocytic syndrome and influenza infection including 4 case reports and 1 autopsy study.
Five manuscripts were reviewed regarding endocrine complications of influenza infection, including 2 case reports, 1 case series, 1 cohort study, and 1 time series.
